Stocks That Moved On No News VBI Vaccines Inc. (VBIV) closed Tuesday's trading at $3.36, up 21.30%. (RTTNews) - Today's Daily Dose brings you news about the pipeline progress of Annovis Bio, new entrants in the COVID-19 drug development space, Livongo Health's upbeat preliminary Q2 revenue, Regeneron's BARDA contract, Novavax stock price touching new high and Mallinckrodt's near-term regulatory catalyst. CPI-006 is also being studied in a phase 1/1b clinical trial as monotherapy and in combination with investigational Ciforadenant or Merck's Keytruda in patients with a variety of cancers who have failed standard therapies.